Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism A2aR antagonists(Adenosine A2a receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Teon Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Teon Therapeutics, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Preclinical | US | Teon Therapeutics, Inc.Startup | 12 Jan 2020 |
Breast Cancer | Preclinical | US | Teon Therapeutics, Inc.Startup | 13 Dec 2019 |
Colorectal Cancer | Preclinical | US | Teon Therapeutics, Inc.Startup | 08 Dec 2019 |